https://stockwhiz.ai/news/faraday-future-founder-and-global-ceo-yt-jia-shares-weekly-investor-up-f414e743Stockwhizen2026-10-18T23:30:00.076ZFaraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: FFR to Hold Listing Ceremony and First Investor Day at the Nasdaq Tower on Oct. 26; Three New Robotics Product Offerings Launchedhttps://stockwhiz.ai/news/aura-q3-2026-earnings-call-and-quarterly-results-cd8bc0fbStockwhizen2026-10-18T23:03:52.664ZAura Q3 2026 Earnings Call and Quarterly Resultshttps://stockwhiz.ai/news/esmo-2026-presentations-deepen-the-evidence-base-for-natera-s-oncology-f9ed8503Stockwhizen2026-10-18T22:10:00.075ZESMO 2026 Presentations Deepen the Evidence Base for Natera’s Oncology Portfolio and Leadership in Ultrasensitive MRD Technologyhttps://stockwhiz.ai/news/abbvie-to-present-data-at-the-2026-european-society-for-medical-oncolo-0c67610eStockwhizen2026-10-18T22:10:00.018ZAbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfoliohttps://stockwhiz.ai/news/zentalis-pharmaceuticals-announces-first-overall-survival-data-for-aze-70bb4e4cStockwhizen2026-10-18T22:05:00.122ZZentalis Pharmaceuticals Announces First Overall Survival Data for Azenosertib from DENALI Part 1b Published in ESMO Congress 2026 Abstracthttps://stockwhiz.ai/news/eikon-therapeutics-announces-availability-of-seven-abstracts-for-prese-1bc039f9Stockwhizen2026-10-18T22:05:00.101ZEikon Therapeutics Announces Availability of Seven Abstracts for Presentation at the European Society for Medical Oncology Congresshttps://stockwhiz.ai/news/incyte-to-highlight-key-oncology-data-presentations-at-the-european-so-3bedbd53Stockwhizen2026-10-18T22:05:00.068ZIncyte to Highlight Key Oncology Data Presentations at the European Society for Medical Oncology (ESMO) Congress 2026https://stockwhiz.ai/news/lilly-to-showcase-advances-across-its-oncology-pipeline-at-the-2026-eu-bbf8c17aStockwhizen2026-10-18T22:05:00.022ZLilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congresshttps://stockwhiz.ai/news/veradermics-to-hold-conference-call-to-discuss-topline-results-from-ph-d274ff0cStockwhizen2026-10-18T22:00:00.081ZVeradermics to Hold Conference Call to Discuss Topline Results from Phase 3 ‘304’ Clinical Trial of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Losshttps://stockwhiz.ai/news/evercore-appoints-nigel-dawn-and-naveen-nataraj-as-co-presidents-a8116efbStockwhizen2026-10-18T21:00:00.140ZEvercore Appoints Nigel Dawn and Naveen Nataraj as Co-Presidentshttps://stockwhiz.ai/news/disc-medicine-to-host-corporate-webcast-to-discuss-topline-results-fro-84469e95Stockwhizen2026-10-18T21:00:00.092ZDisc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP)https://stockwhiz.ai/news/where-are-the-numbers-doug-bergeron-calls-on-ethan-allen-to-release-fi-4c55f5e5Stockwhizen2026-10-18T20:00:00.072Z“Where Are the Numbers?” Doug Bergeron Calls on Ethan Allen to Release First Quarter Results Before November 4 Board Votehttps://stockwhiz.ai/news/spyre-therapeutics-announces-clinical-and-preclinical-data-presentatio-cd5a4d17Stockwhizen2026-10-18T13:30:00.094ZSpyre Therapeutics Announces Clinical and Preclinical Data Presentations at United European Gastroenterology Week (UEGW) 2026https://stockwhiz.ai/news/jinkosolar-unveils-tiger-neo-5-0-all-black-residential-solar-module-wi-9533bb56Stockwhizen2026-10-17T11:33:26.908ZJinkoSolar Unveils Tiger Neo 5.0 All-Black Residential Solar Module with 25.52% Efficiencyhttps://stockwhiz.ai/news/skyrizi-risankizumab-and-rinvoq-upadacitinib-data-highlight-long-term--0376d7b4Stockwhizen2026-10-17T06:00:00.075ZSKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026https://stockwhiz.ai/news/ballard-announces-q3-2026-results-conference-call-67d22a38Stockwhizen2026-10-17T02:30:00.035ZBallard Announces Q3 2026 Results Conference Callhttps://stockwhiz.ai/news/nip-group-inc-announces-results-of-extraordinary-general-meeting-4d5988cfStockwhizen2026-10-17T01:55:01.741ZNIP Group Inc. Announces Results of Extraordinary General Meetinghttps://stockwhiz.ai/news/align-technology-wins-significant-patent-infringement-case-against-ang-a8010e8cStockwhizen2026-10-17T01:11:00.102ZAlign Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent Court